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of energy transduction and ATP synthesis. 
This book will clearly be of most use to those 
working on energy transduction and oxidative phos- 
phorylation in mitochondria. Its interest for others 
will be limited by the fragmentary coverage of mem- 
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With some notable exceptions biochemists have 
until recently been unaware of the intricacies of cellu- 
lar interactions with the cate~llolalnines. It has been 
enough in most studies to demonstrate that a given 
process (or reaction) is stimulated or inhibited by the 
cate~holamines and little attention has been paid to 
the characteristics of the receptor which is involved. 
Two developments have made adrenergic pharma- 
cology a topic of considerable importance to bio- 
chemists interested in cellular responses to the 
catecholamines and in the mechanisms involved in 
intracelhrlar transmission of the signals generated by 
the interaction of the catecholamine with its plasma 
membrane receptor. First, it is now well recognised 
that the nature of the stimulus-response coupling 
mechanisms is related to the type of catecholamine 
receptor which is present on the cell under study. 
For example, /3,-adrenoceptors appear in most, if 
not all, instances to mediate their effects via activa- 
tion of adenylate cyclase and an increase in the con- 
centration of cyclic 3’,5’-AMP. In contrast, o-adreno- 
ceptors do not appear to utilise this mechanism and 
current evidence, although far from conclusive, 
implicates changes in cytosolic Ca*+ concentration 
as a crucial event in the coupling sequence, associated 
in some cases at least with inhibition of adenylate 
cyclase. Second, adrenergic pharmacology has pro- 
duced a very wide range of drugs with widely variant 
selectivities for the different adrenoceptor types 
and sub-types. The selectivity of such compounds 
can be employed to good purpose in investigations of 
the metabolic effects of the ~ate~holam~es, although 
as yet they have not been widely exploited. There is 
therefore plenty here of interest to the biochemist; 
ail that is needed is a well-informed and sympathetic 
brane phenomena provided especially as a number of 
the other topics covered, although undoubtedly inter- 
esting, are unexpectedly specialised for a relatively slim 
book with such a very general title. 
J. A. Lucy 
guide to the unfamiliar realms of pharmacology, a role 
for which Dr Lefkowitz is uniquely well qualified. 
In this book Drs Lefkowitz and W~liams provide a 
lucid and extremely readable introduction to adrenergic 
pharmacology. Although the focus is on the use of 
binding studies to characterise adrenoceptors the book 
provides also an excellent account of the background 
to adrenoceptor classification. In addition, the binding 
data are set into their physiological context and the 
authors consider how such studies can provide infor- 
mation on the regulation of tissue responsiveness to 
catecholamines. On a more practical level the theory 
of the ligand-receptor interaction is developed and 
various problems inherent in the theory are considered 
while an entire chapter is devoted to the methodology 
required to obtain meaningful binding data on adre- 
nergic receptors. The latter will be of particular 
value to any workers contemplating a study of this 
type since it contains practical advice on the diffi- 
culties likely to be encountered. 
I have therefore no hesitation in recommending 
this book most highly to anyone whose studies cover 
the topic of cellular interactions with catecholamines 
whether or not bindng studies are contemplated. My 
only reservation is the rapidity with which this field 
is moving at present. For example, in respect to 
Dr Lefkowitz’s own studies, the book makes no men- 
tion of the elegant use of selective antagonists coupled 
with computer analysis of the binding curves which 
allows objective analysis of data obtained for tissues 
containing more than CX- (or /3-) adrenoceptor sub-type. 
Perhaps a revised edition (or volume 2) will allow for 
these and other important developments. 
M. C. Scrutton 
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